Recombinant Human CD30/TNFRSF8/CD30L Receptor (C-6His)

Recombinant Human CD30/TNFRSF8/CD30L Receptor (C-6His)

SKU: C643-10ug
$90.00Price
Recombinant Human CD30 is produced by our Mammalian expression system and the target gene encoding Phe19-Lys379 is expressed with a 6His tag at the C-terminus. Bon Opus Cat. #C643
Size
  • Accession Number

    P28908
  • Background

    CD30, also known as TNFRSF8, is a cell membrane protein of the tumor necrosis factor receptor family, which regulates proliferation/apoptosis and antibody responses. CD30 is expressed by activated, but not by resting, T and B cells. Aberrant expression of CD30 by mastocytosis mast cells and interaction with its ligand CD30L (CD153) appears to play an important role in the pathogenesis and clinical presentation of systemic mastocytosis. CD30 has been considered as a specific diagnostic biomarker of anaplastic large cell lymphoma (ALCL) and classical Hodgkin lymphoma (cHL). CD30 is also a biomarker used for targeted therapy by an antibody–drug conjugate.
  • Expression

    Human Cells
  • Packaging

    Ambient
  • Formulation

    Lyophilized from a 0.2 μm filtered solution of 20mM Tris,150mM NaCl,pH7.5 .
  • ALTnames

    Tumor necrosis factor receptor superfamily member 8; CD30L receptor; Ki-1 antigen; Lymphocyte activation antigen CD30; CD30; TNFRSF8
Blue%20DNA%20(stock%20photo)_edited.jpg
  • Twitter
  • Facebook
  • LinkedIn

Terms and Conditions  I  Privacy Policy  I  Legal  I  Sitemap ©2020 by Bon Opus Biosciences, LLC.     150 Essex St, Millburn, NJ 07041, USA